Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Indoco Remedies Ltd

NSE: INDOCO · BSE: 532612 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹246.55
Market cap
₹2,276 Cr
Revenue (annual)
₹1,845 Cr
Net profit (annual)
₹-95.14 Cr
P/E (TTM)
404.2×Sector 47.3×
Promoter holding
58.86%+0.00% QoQ
FII holding
1.27%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:37 IST NSE
Business Update

Indoco Remedies Business Update

Indoco Remedies received seven USFDA observations in Form 483 for its Plant II (Sterile) facility in Goa following an inspection from August 27 to September 4, 2026.

16:37 IST BSE
Business Update

Indoco Remedies Business Update

Indoco Remedies Limited has executed a Deed of Conveyance to sell a plot of land located at Mahal Industrial Estate to Kalpataru Townships Private Limited.

16:01 IST BSE
Business Update

Indoco Remedies Business Update

Indoco Remedies has executed a deed of conveyance to sell a land plot in Mumbai for a total consideration of ₹64 Crore.

Value
₹64.00 Cr
12:20 IST NSE
Business Update

Indoco Remedies Business Update

Indoco Remedies' Goa plant successfully cleared an inspection by the Malta Medicines Authority. The facility received EU GMP certification for solid oral dosage forms.